Search

Maravai LifeSciences Holdings Inc (Class A)

Fechado

SetorSaúde

6.79 -3.96

Visão Geral

Variação de preço das ações

24h

Atual

Mín

6.73

Máximo

6.83

Indicadores-chave

By Trading Economics

Rendimento

-21M

-24M

Vendas

-14M

51M

EPS

-0.07

Margem de lucro

-47.189

Funcionários

415

EBITDA

-16M

-3.6M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+15.98% upside

Dividendos

By Acuity

Próximos Ganhos

4 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

247M

2.6B

Abertura anterior

10.75

Fecho anterior

6.79

Maravai LifeSciences Holdings Inc (Class A) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de out. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc shares are declining, having pulled back significantly since Thursday's close and remaining near the lower end of its one-month trading range.

15 de out. de 2026, 20:02 UTC

News

DBAB analysts express confidence in Maravai LifeSciences, anticipating it will exceed Q326 estimates and raise full-year guidance, contributing to the stock's upward movement.

14 de out. de 2026, 19:46 UTC

Maravai LifeSciences Holdings Inc is trading higher, having reached a peak return earlier today, though it remains below its 20-day moving average.

13 de out. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, reversing a recent trend of higher daily closes amid a broader decline since Monday.

12 de out. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, reversing recent gains and diverging from the upward momentum observed since Friday's close.

9 de out. de 2026, 20:06 UTC

Maravai LifeSciences Holdings Inc shares are advancing, contributing to broader market gains, with notable upward momentum observed since Thursday's close despite recent lower finishes.

8 de out. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc shares fell sharply during Thursday's trading session, continuing a trend of lower closes despite an earlier recovery from session lows.

7 de out. de 2026, 20:00 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, continuing a downward trend that diverges from recent higher daily closes since Tuesday's close.

6 de out. de 2026, 20:00 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, reversing a trend of higher daily closes established in recent sessions.

5 de out. de 2026, 20:01 UTC

News

Maravai LifeSciences shares are higher as TD Cowen initiated coverage with a Buy rating and a $9 price target.

1 de out. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, pulling back from earlier gains and contrasting with the previous three sessions that ended higher.

29 de set. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc is seeing modest gains, maintaining stable performance and remaining above its 20-day moving average during Tuesday's trading session.

25 de set. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc shares fell, reflecting a modest decline since Thursday, amid a broader market drop before a partial recovery.

24 de set. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc shares are up significantly, currently trading well above its 20-day moving average and around the midpoint of its one-month range.

22 de set. de 2026, 19:51 UTC

Maravai LifeSciences Holdings Inc is gaining ground in Tuesday's market session, continuing a trend of higher movement since Monday's close.

18 de set. de 2026, 20:02 UTC

Maravai LifeSciences Holdings Inc shares fell sharply, remaining below the 20-day moving average and experiencing notable volatility since Thursday's close.

17 de set. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc is advancing sharply, building on recent gains, despite pulling back slightly earlier in the session while remaining above its opening price.

11 de set. de 2026, 20:08 UTC

Maravai LifeSciences Holdings Inc is trading lower today, continuing a decline seen over the past six sessions amid broader market weakness.

10 de set. de 2026, 23:11 UTC

Maravai LifeSciences Holdings Inc shares are lower in after-market trading, continuing a trend of declines with no specific news to explain the movement.

9 de set. de 2026, 20:07 UTC

News

Maravai LifeSciences Holdings Inc shares declined, closing at their lowest point of the day after UBS raised its price target to $8.

4 de set. de 2026, 19:16 UTC

Maravai LifeSciences Holdings Inc is trading higher during Friday's session, recovering from an early decline and remaining above its 20-day moving average. No specific news identified.

3 de set. de 2026, 19:46 UTC

Maravai LifeSciences Holdings Inc is trading lower today, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

1 de set. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc is lower today, marking five consecutive sessions of declines amid rising oil prices and inflation concerns affecting market sentiment.

31 de ago. de 2026, 20:07 UTC

Maravai LifeSciences Holdings Inc is lower today, marking five consecutive days of declines amid concerns over inflation and interest rate hikes from the Jackson Hole symposium.

28 de ago. de 2026, 20:01 UTC

Shares of Maravai LifeSciences Holdings Inc are trading lower today, breaking a trend of higher closes amid rising U.S. Treasury yields and inflation concerns.

27 de ago. de 2026, 20:01 UTC

Maravai LifeSciences Holdings Inc is trading lower, falling below its 20-day moving average amid no specific news to explain the decline.

26 de ago. de 2026, 20:08 UTC

Maravai LifeSciences is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with no specific company news identified.

25 de ago. de 2026, 20:07 UTC

Maravai LifeSciences is trading higher, supported by favorable market conditions amid declining oil prices and lower Treasury yields. Shares pulled back from earlier session highs.

24 de ago. de 2026, 20:06 UTC

Maravai LifeSciences is declining amid broader market pressures from rising oil prices and geopolitical tensions, despite reaching a session high earlier.

21 de ago. de 2026, 19:43 UTC

Maravai LifeSciences Holdings Inc is trading higher today, supported by increased investor interest and unusually high trading volume, despite no specific news identified.

Comparação entre Pares

Variação de preço

Maravai LifeSciences Holdings Inc (Class A) Previsão

Preço-alvo

By TipRanks

15.98% parte superior

Previsão para 12 meses

Média 7.875 USD  15.98%

Máximo 9 USD

Mínimo 6.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Maravai LifeSciences Holdings Inc (Class A) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
help-icon Live chat